Danaher Stock Outlook: Is Wall Street Bullish or Bearish?

Washington, the District Of Columbia-based Danaher Corporation (DHR) is a global leader in science and technology focused on driving innovation in life sciences, diagnostics, and biotechnology. Valued at a market cap of $152.4 billion, the company designs, manufactures, and markets instruments, consumables, and services that support drug discovery, genomics, molecular diagnostics, and lab automation. 

This healthcare company has considerably underperformed the broader market over the past 52 weeks. Shares of DHR have declined 8.4% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.5%. Moreover, on a YTD basis, the stock is down 4.4%, compared to SPX’s 16.5% return.